Most branded pharmaceuticals lose patent exclusivity and eventually face generic competition. The size of the U.S. market and the relatively low barrier of entry for generic products typically breeds competition between generic manufacturers.
You may also be interested in
You are about to exit for another IQVIA country or region specific website
Please be aware that the website you have requested is intended for the residents of particular country or region, as noted on that site.